A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
A systematic review and meta-analysis of 62 studies has found that immunity conferred by the measles, mumps, and rubella (MMR) vaccine fades each subsequent year, suggesting that vaccination strategies should be revisited.
Seemingly healthy people with COVID-19 can spread the disease to others as soon as 2 days after infection, an analysis of a coronavirus cluster traced to four live music clubs in Osaka, Japan, shows.
University of California researchers studying the breast milk of 18 women with COVID-19 found coronavirus RNA—but not live virus—in 1 of 64 samples, suggesting that babies aren't likely to be infected through that route.
The southern half of the country continues to report the highest death tolls, which nationally may be higher than thought, based on new excess death estimates.
Meanwhile, experts warn that a window of opportunity to control the virus is short, ahead of a likely new COVID-19 surge in the fall.
COVID-19 genetic material—not necessarily live virus—was found on surfaces in a 1-meter (3.3-foot) diameter circle where asymptomatic patients who had passed coronavirus triage had eye exams, according to a small study published yesterday in JAMA Ophthalmology.
A phase 3 clinical trial involving 531 people living along the China-Myanmar border has shown that the antimalarial-antibacterial drug combination naphthoquine-azithromycin (NQAZ) is effective in preventing malarial Plasmodium infections.
The Centers for Disease Control and Prevention (CDC) said there were 303 additional cases of cyclosporiasis in a multistate outbreak linked to bagged salads sold at major grocery stores.
The CDC said 509 people in eight states have been sickened. Thirty-three people have been hospitalized, but there have been no deaths.
In household contacts, 14% who got a placebo developed flu, compared with 2% in the baloxavir group.
More than 10% of swine workers tested had antibodies to the novel influenza strain.
